Skip to main content
VCbacked
Log inGet Started

Cambridge Epigenetix

Cambridge, United Kingdom

Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.

$88.0M raised
Nov 2021
Series D
BiotechnologyHealth CareHealth DiagnosticsMedical

Top Investors

TemasekSequoia CapitalThird Point VenturesGoogle VenturesAhren Innovation Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cambridge Epigenetix

How much funding has Cambridge Epigenetix raised?
Cambridge Epigenetix has raised $88.0M in total funding. The most recent round was Series D. The last funding was announced in November 2021.
Who are Cambridge Epigenetix's investors?
Cambridge Epigenetix's investors include Temasek, Sequoia Capital, Third Point Ventures, Google Ventures, Ahren Innovation Capital.
Where is Cambridge Epigenetix headquartered?
Cambridge Epigenetix is headquartered in Cambridge, United Kingdom.
What does Cambridge Epigenetix do?
Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
What stage is Cambridge Epigenetix at?
Cambridge Epigenetix is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cambridge Epigenetix — Funding & Investors." VCBacked, November 2, 2021, https://www.vcbacked.co/company/cambridge-epigenetix. Accessed July 1, 2026.
APA
VCBacked. (2021). Cambridge Epigenetix — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/cambridge-epigenetix
Wikipedia (cite web)
{{cite web |title=Cambridge Epigenetix — Funding & Investors |url=https://www.vcbacked.co/company/cambridge-epigenetix |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K